Dr Carrie Willcox
Supervisor Details
Research Interests
Vertebrate adaptive immunity relies on three types of lymphocytes that use V(D)J rearrangement to generate diverse antigen receptors capable of recognising diverse antigenic challenges. While the role of B cells and “conventional” alpha/beta T cells have been well described, the role of gamma/delta T cells remains less clear. gamma/delta T cells are often thought of as unconventional, “innate-like” lymphocytes, which respond quickly to immune challenges and recognise a limited set of conserved ligands.
In recent years, we have used T cell receptor (TCR) repertoire analysis, flow cytometry and functional experiments to show that some human gamma/delta T cells (Vγ9Vδ2 T cells) are indeed innate-like, while others (non-Vγ9Vδ2 T cells) have adaptive-like properties similar to conventional alpha/beta T cells. The lab focuses on four main areas:
- Characterising butyrophilin ligands for innate-like gamma/delta T cells.
- Identifying ligands for adaptive-like human gamma/delta T cells in viral infection and cancer.
- Investigating the development of human gamma/delta T cells in the thymus.
- Characterising the localisation, phenotype and function of gamma/delta T cells in human tissues.
Scientific Inspiration
I’m inspired by the scientists who helped us understand alpha/beta T cell recognition of antigenic peptide-MHC complexes: Rolf Zinkernagel and Peter Doherty, who received the Nobel Prize in 1996, but also others like Alain Townsend, Pamela Bjorkman, Don Wiley, and Peter Cresswell, who defined how this happens at the molecular level.
Research Groups
MIBTP Project Details
Primary supervisor for: